Primerica, Inc. (PRI) stock
PRINYSELife InsuranceFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3013% above fair value
$291.96−3.65 (-1.23%)
Close on Nov 12, 2026Market cap $8.99BP/E 11.5Yield 1.42%
Primerica EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Primerica's EPS for the twelve months ending Sep 30, 2026 was $25.31, up 16.3% year over year. For fiscal 2025 it was $22.91, up 67.1% from the year before. Over ten years it grew 20.0% a year on average. The highest annual figure on record is $22.91 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.91 | +67.1% |
| FY2024 | Dec 31, 2024 | $13.71 | -14.0% |
| FY2023 | Dec 31, 2023 | $15.94 | +29.3% |
| FY2022 | Dec 31, 2022 | $12.33 | +2.8% |
| FY2021 | Dec 31, 2021 | $11.99 | +25.3% |
| FY2020 | Dec 31, 2020 | $9.57 | +11.0% |
| FY2019 | Dec 31, 2019 | $8.62 | +17.6% |
| FY2018 | Dec 31, 2018 | $7.33 | -3.7% |
| FY2017 | Dec 31, 2017 | $7.61 | +65.8% |
| FY2016 | Dec 31, 2016 | $4.59 | +24.1% |
| FY2015 | Dec 31, 2015 | $3.70 | +12.5% |
| FY2014 | Dec 31, 2014 | $3.29 | +16.3% |
| FY2013 | Dec 31, 2013 | $2.83 | +4.4% |
| FY2012 | Dec 31, 2012 | $2.71 | +30.3% |
| FY2011 | Dec 31, 2011 | $2.08 | -32.0% |
| FY2010 | Dec 31, 2010 | $3.06 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.76 | +6.5% |
| Q2 FY2026 | Jun 30, 2026 | $6.45 | +19.4% |
| Q1 FY2026 | Mar 31, 2026 | $5.97 | +18.2% |
| Q4 FY2025 | Dec 31, 2025 | $6.13 | +23.6% |
| Q3 FY2025 | Sep 30, 2025 | $6.35 | +31.5% |
| Q2 FY2025 | Jun 30, 2025 | $5.40 | +17900.0% |
| Q1 FY2025 | Mar 31, 2025 | $5.05 | +28.5% |
| Q4 FY2024 | Dec 31, 2024 | $4.96 | +15.3% |
| Q3 FY2024 | Sep 30, 2024 | $4.83 | +14.2% |
| Q2 FY2024 | Jun 30, 2024 | $0.03 | -99.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.93 | +13.6% |
| Q4 FY2023 | Dec 31, 2023 | $4.30 | -30.2% |
| Q3 FY2023 | Sep 30, 2023 | $4.23 | +100.5% |
| Q2 FY2023 | Jun 30, 2023 | $3.97 | +19.9% |
| Q1 FY2023 | Mar 31, 2023 | $3.46 | +18.9% |
| Q4 FY2022 | Dec 31, 2022 | $6.16 | +77.0% |
| Q3 FY2022 | Sep 30, 2022 | $2.11 | -25.2% |
| Q2 FY2022 | Jun 30, 2022 | $3.31 | +2.8% |
| Q1 FY2022 | Mar 31, 2022 | $2.91 | +18.3% |
| Q4 FY2021 | Dec 31, 2021 | $3.48 | +38.1% |
| Q3 FY2021 | Sep 30, 2021 | $2.82 | +0.4% |
| Q2 FY2021 | Jun 30, 2021 | $3.22 | +28.3% |
| Q1 FY2021 | Mar 31, 2021 | $2.46 | +40.6% |
| Q4 FY2020 | Dec 31, 2020 | $2.52 | +12.5% |
| Q3 FY2020 | Sep 30, 2020 | $2.81 | +23.2% |
| Q2 FY2020 | Jun 30, 2020 | $2.51 | +10.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.75 | -4.4% |
| Q4 FY2019 | Dec 31, 2019 | $2.24 | +12.6% |
| Q3 FY2019 | Sep 30, 2019 | $2.28 | +17.5% |
| Q2 FY2019 | Jun 30, 2019 | $2.28 | +16.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.83 | +25.3% |
| Q4 FY2018 | Dec 31, 2018 | $1.99 | -46.5% |
| Q3 FY2018 | Sep 30, 2018 | $1.94 | +32.9% |
| Q2 FY2018 | Jun 30, 2018 | $1.95 | +43.4% |
| Q1 FY2018 | Mar 31, 2018 | $1.46 | +31.5% |
| Q4 FY2017 | Dec 31, 2017 | $3.72 | +207.4% |
| Q3 FY2017 | Sep 30, 2017 | $1.46 | – |
| Q2 FY2017 | Jun 30, 2017 | $1.36 | – |
| Q1 FY2017 | Mar 31, 2017 | $1.11 | – |
| Q4 FY2016 | Dec 31, 2016 | $1.21 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?